{"id":"W4283169331","doi":"10.1007/s40268-022-00391-6","title":"Analysis of the US Safety Data for Edaravone (Radicava®) From the Third Year After Launch","year":2022,"lang":"en","type":"article","venue":"Drugs in R&D","topic":"Amyotrophic Lateral Sclerosis Research","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"ca_institutions":"Montreal Neurological Institute and Hospital","funders":"","keywords":"Medicine; Adverse effect; Edaravone; Amyotrophic lateral sclerosis; Postmarketing surveillance; Clinical trial; Disease; Intensive care medicine; Internal medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0009292496,0.00008663112,0.0002931331,0.0000811748,0.0001200198,0.00001076751,0.0008948381,0.00003994565,0.001833807],"category_scores_gemma":[0.0001997368,0.00004720296,0.0001463403,0.0009622342,0.0001345387,0.0000392133,0.001061226,0.0003762274,0.000007933384],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001256818,"about_ca_system_score_gemma":0.0001125716,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001863285,"about_ca_topic_score_gemma":0.0003430312,"domain_scores_codex":[0.9983063,0.0002074223,0.0002842933,0.0003062452,0.0006683028,0.0002274709],"domain_scores_gemma":[0.9978632,0.0003701098,0.00007253588,0.001607295,0.00004183326,0.00004504184],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.002997479,0.0004737742,0.9456369,0.00004278885,0.002610825,0.00001074146,0.005016412,0.001104547,0.002074515,0.0004029872,0.03471693,0.00491206],"study_design_scores_gemma":[0.0009107537,0.00004317677,0.9392733,0.00001969253,0.0004714787,3.855957e-7,0.0003673829,0.007441174,0.00003518862,0.0001024051,0.05127342,0.00006166384],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9864593,0.0003161927,0.00004086996,0.009442679,0.0001191333,0.0005966433,0.002277102,0.00001023244,0.0007378614],"genre_scores_gemma":[0.9972146,0.00005335837,0.000234778,0.0009196721,0.0001047748,0.00009651908,0.0004096297,0.00001497711,0.0009517167],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01655649,"threshold_uncertainty_score":0.9990786,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03374131150750272,"score_gpt":0.3130737246580986,"score_spread":0.2793324131505959,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}